Skip to Content

Pfizer 5 XNB (Inlyta 5 mg)

Generic Name: axitinib

Pill with imprint Pfizer 5 XNB is Red, Three-sided and has been identified as Inlyta 5 mg. It is supplied by Pfizer Inc..

Inlyta is used in the treatment of renal cell carcinoma and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Inlyta 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer 5 XNB

Inlyta 5 mg Pfizer 5 XNB

Inlyta

Generic Name
axitinib
Imprint
Pfizer 5 XNB
Strength
5 mg
Color
Red
Size
8.00 mm
Shape
Three-sided
Availability
Prescription only
Drug Class
Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer Inc.
National Drug Code (NDC)
00069-0151
Inactive Ingredients
microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, magnesium stearate, titanium dioxide, triacetin, ferric oxide red, hypromellose 2910 (15000 mPa.s)

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.